The shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA) started off the last trading session with the price of $4.29 while closing the day with the price of $4.13. The shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA) Fell -2.59% with the Loss of -0.16 points.
The shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA) traded with the day volume of 2.06 Million shares whereas its average trading volume is 3.15 Million.
While analyzing the past performance of the stock we can see that the shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA) Loss -1.43% in the last week while Falling -13.42% in the last month. Past quarter performance shows the red light with -19.18%. The semi-annual and annual performance shows 19.71% and -43.58% respectively.
Some critical values of the shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA) to be discussed here are: the beta which shows the value at 2.19 while Average True Range of Fairmount Santrol Holdings Inc. (NYSE:FMSA) demonstrate the value at 0.28. The weekly and monthly volatility of the shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA) are indicated at 4.56% and 5.91%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 31.72.
While studying the financial position of the shares of Fairmount Santrol Holdings Inc. (NYSE:FMSA), we can see that the Market capitalization of the company is at 895.55 Million. The shares outstanding for the company is 216.84 Million and the shares float stands at 204.43 Million. The income of the company stand at 53.8 Million while the sales stand at 959.8 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.24, Price to Earnings or P/E is at 17.5, Price to Sales P/S show the value of 0.93, the Return on Asset ROA stood at -0.034 and the Return on Equity ROE depicted at -0.159 while Return on Investment ROI is at -0.068.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) started its previous trading session at $36.24 and closed at $33.01 showing a Fell of -8.38 Percent.
The Company traded with an average Volume of 605.19 Million whereas, its Day Volume stood at 2.04 Million.
Looking at the performance of the stock, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Loss -20.71% in the last week in its shares price and -17.39% in the last month. Quarterly performance shows a green of 7.59 Percent while Semi-Annual and Annual performances shows a 37.14 and 106.31 percent respectively.
Beta for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stands at 1.55 while the ATR (average true range) is at 2.42. The Stock’s Weekly and Monthly Volatility is 8.34% and 5.94% respectively showing a RSI value of 30.69.
While studying the financial position of the shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), we can see that the Market capitalization of the company is at 1.28 Billion. The shares outstanding for the company is 38.67 Million and the shares float stands at 38.67 Million.
The Company generated an income of -39200000 and the sales of 106.4 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.94 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 12 respectively.
The Return on Assets stands at -0.185, ROE shows a value of -0.426 and ROI for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is -0.163 as of Trailing Twelve Months period.
